Literature DB >> 3730768

Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy.

R D Oberhaensli, G J Galloway, D J Taylor, P J Bore, G K Radda.   

Abstract

Phosphorus 31 magnetic resonance (MR) spectroscopy was used for the study of liver metabolism in vivo in seven healthy subjects. Subjects were examined in a 1.6 T whole-body magnet using surface coils for data acquisition. The region of the liver from which MR signals were collected was selected by magnetic-field profiling. The concentration ratios of adenosine triphosphate (ATP), inorganic phosphate (Pi) and sugar phosphates contained in liver cells could be reproducibly assessed. Cytosolic pH and the free magnesium concentration were determined to be 7.18 and 300 microM, respectively. During intravenous fructose tolerance tests the hepatic concentrations of sugar phosphates, ATP and Pi altered markedly. During the first 5 min following bolus injection of 250 mg fructose/kg body weight the concentration of sugar phosphates increased sevenfold whereas Pi and ATP decreased by three- to fourfold. Metabolism of sugar phosphates was complete within 20 min and could be followed by 31P MR with a time resolution of 5 min. Thus, 31P MR spectroscopy yields insight into liver metabolism which has not been accessible so far using conventional non-invasive methods. In conjunction with intravenous fructose loading, 31P MR spectroscopy may provide a means for the functional assessment of the liver.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3730768     DOI: 10.1259/0007-1285-59-703-695

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  18 in total

Review 1.  NMR studies of drug metabolism and disposition.

Authors:  J D Bell; D G Gadian; N E Preece
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 2.  Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.

Authors:  Pieter C Dagnelie; Susanne Leij-Halfwerk
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

3.  Simultaneous synthesis and degradation of rat liver glycogen. An in vivo nuclear magnetic resonance spectroscopic study.

Authors:  M David; W A Petit; M R Laughlin; R G Shulman; J E King; E J Barrett
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

Review 4.  The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview.

Authors:  Dimitrios Tsilingiris; Evangelia Tzeravini; Chrysi Koliaki; Maria Dalamaga; Alexander Kokkinos
Journal:  Curr Obes Rep       Date:  2021-04-10

5.  Soft drinks consumption and nonalcoholic fatty liver disease.

Authors:  William Nseir; Fares Nassar; Nimer Assy
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

6.  Study of human liver disease with P-31 magnetic resonance spectroscopy.

Authors:  R Oberhaensli; B Rajagopalan; G J Galloway; D J Taylor; G K Radda
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

7.  Soft drink consumption linked with fatty liver in the absence of traditional risk factors.

Authors:  Nimer Assy; Gattas Nasser; Iad Kamayse; William Nseir; Zaza Beniashvili; Agness Djibre; Maria Grosovski
Journal:  Can J Gastroenterol       Date:  2008-10       Impact factor: 3.522

8.  Influence of different fasting periods on P-31-MR-spectroscopy of the liver in normals and patients with liver metastases.

Authors:  G Brinkmann; U H Melchert; C Muhle; J Brossmann; J Link; M Reuter; M Heller
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

9.  In vivo study of brain metabolism in galactosemia by 1H and 31P magnetic resonance spectroscopy.

Authors:  H E Möller; K Ullrich; P Vermathen; G Schuierer; H G Koch
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

10.  Fructose consumption as a risk factor for non-alcoholic fatty liver disease.

Authors:  Xiaosen Ouyang; Pietro Cirillo; Yuri Sautin; Shannon McCall; James L Bruchette; Anna Mae Diehl; Richard J Johnson; Manal F Abdelmalek
Journal:  J Hepatol       Date:  2008-03-10       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.